Evaluating the NHS research and development programme: will the programme give value for money?

. 1998;91(Suppl 35):2–6. doi: 10.1177/014107689809135s02

PMCID: PMC1296356 PMID: 9797742

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Buxton M., Hanney S. How can payback from health services research be assessed? J Health Serv Res Policy. 1996 Jan;1(1):35–43. [PubMed] [Google Scholar]
Detsky A. S. Are clinical trials a cost-effective investment? JAMA. 1989 Oct 6;262(13):1795–1800. [PubMed] [Google Scholar]
Koopmanschap M. A., Rutten F. F. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics. 1993 Dec;4(6):446–454. doi: 10.2165/00019053-199304060-00006. [DOI] [PubMed] [Google Scholar]
Peckham M. Research and development for the National Health Service. Lancet. 1991 Aug 10;338(8763):367–371. doi: 10.1016/0140-6736(91)90494-a. [DOI] [PubMed] [Google Scholar]